VERV: One to Keep an Eye On

VERV: One to Keep an Eye On

Apr 15, 2025

Hey everyone, Barrie Einarson here with a trade breakdown that’s not about what’s happening right now—but what could be setting up beneath the surface. The ticker? VERV. To Subscribe: https://go.trade-ideas.com/SHQ
Use Promo Code BARRIE15 for 15% off

This one came through on an AI alert at $5.71, but since then, it’s pulled back to around $5.16. Not the kind of action that grabs your attention immediately—but that’s exactly why I wanted to talk about it. Sometimes, the best setups come from watching before acting.

Here’s what made me take a second look at VERV: the analyst sentiment. I counted around seven or eight analysts who’ve recently put out bullish reports. That’s not common for a stock trading in this range. JP Morgan has a $16 price target on it, and the highest target I saw was up near $35. That kind of spread tells me there’s long-term conviction building.

Then there’s the news catalyst. It looks like VERV announced some kind of partnership or deal with Eli Lilly just yesterday. I don’t have all the details yet, but when a smaller biotech gets connected with a name like Lilly, it’s not something I ignore. That kind of backing can open a lot of doors.

The float on VERV is about 65 million shares—so not exactly low-float territory, but still lean enough to move on volume. If we start to see institutional buying or retail interest build up off the analyst chatter or deal news, this could get legs quickly.

For now, this isn’t a trade I’m entering immediately—but it’s definitely one to keep on the watchlist. If it starts to base and creep back toward that $5.70 level, or breaks above with volume, I’ll be ready.

Sometimes the best trades don’t start hot—they start quiet.